Related Experiment Video

Updated: Jul 16, 2026

Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells
13:58

Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells

Published on: October 22, 2012

MHC typing in variant Creutzfeldt-Jakob disease

Mark B Pepys1, Alison Bybee, David R Booth

  • 1Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, Rowland Hill Street, NW3 2PF, London, UK. m.pepys@rfc.ucl.ac.uk

Lancet (London, England)
|February 14, 2003
PubMed

Insights

Major Histocompatibility Complex (MHC) types do not influence susceptibility or clinical presentation of variant Creutzfeldt-Jakob disease (vCJD). This study found no significant associations between MHC genotypes and vCJD onset or duration.

Area of Science:

  • Neuroscience
  • Immunogenetics
  • Prion Diseases

Background:

  • Variant Creutzfeldt-Jakob disease (vCJD) is a fatal neurodegenerative disorder.
  • Understanding factors influencing vCJD susceptibility and disease progression is crucial for management.
  • The Major Histocompatibility Complex (MHC) plays a key role in immune responses and disease susceptibility.

Purpose of the Study:

  • To investigate the potential association between MHC genotypes and susceptibility to vCJD.
  • To determine if MHC phenotypes correlate with the clinical expression of vCJD, including age of onset and disease duration.

Main Methods:

  • Genotyping of MHC loci in 76 individuals diagnosed with vCJD.
  • Comparison of MHC genotype frequencies between vCJD patients and 131 healthy controls.
  • Analysis of MHC phenotypes in relation to vCJD age of onset and duration from symptom presentation to death.

Main Results:

  • No significant differences were observed in the frequencies of any MHC types between the vCJD and control populations.
  • No associations were found between specific MHC types and the age of onset for vCJD.
  • MHC type did not correlate with the duration of vCJD from presentation to death.

Conclusions:

  • The findings do not support a role for MHC types in determining susceptibility to developing vCJD.
  • MHC genotypes do not appear to influence the clinical expression or progression of variant Creutzfeldt-Jakob disease.
  • Further research may be needed to identify other genetic or environmental factors affecting vCJD.

More Related Videos

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin11:17

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin

Published on: March 10, 2021

Identification of Rare Antigen-Specific T Cells from Mouse Lungs with Peptide:Major Histocompatibility Complex Tetramers09:15

Identification of Rare Antigen-Specific T Cells from Mouse Lungs with Peptide:Major Histocompatibility Complex Tetramers

Published on: July 19, 2024

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Mismatch Repair01:36

Mismatch Repair

Overview
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...